Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

425 projects found matching your search criteria :

  1. Machine Learning Platform for Personalized Intravitreal Anti-VEGF Therapy Using Drug-Loaded Polymeric Nanoparticles

    Call: M-ERA.NET 3 Call 2025 , Panel: ST11

    Principal investigator: dr Marcin Krzysztof Heljak

    Politechnika Warszawska

  2. Dynamic Quantum Crystallography and Machine Learning for Better Understanding Thermodynamic Stability and Solubility of ...

    Call: SONATA BIS 15 , Panel: ST4

    Principal investigator: dr hab. Anna Agnieszka Hoser

    Uniwersytet Warszawski

  3. Proteomic characterization, transcriptional and epigenetic regulation of drugtransporters in colorectal cancer

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Nina Ewa Komaniecka

    Pomorski Uniwersytet Medyczny w Szczecinie

  4. RNA biology at the phage-bacteria interface

    Call: OPUS 29 , Panel: NZ1

    Principal investigator: dr Ewelina Magdalena Małecka-Grajek

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

  5. Dual-Target Compounds Modulating EAAT2 and Kv7.2/3 Channels: A Rational Strategy Toward Novel Antiseizure and Antinocice...

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: dr Michał Andrzej Abram

    Uniwersytet Jagielloński

  6. Functional nanomaterials based on drug–lipid–ligands as targeted delivery systems for anticancer agents in lung adenocar...

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Piotr Paweł Szyk

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  7. Characterization of microscopic fungi isolated from human cadavers.

    Call: PRELUDIUM 24 , Panel: NZ8

    Principal investigator: Klaudyna Aleksandra Spychała

    Uniwersytet Wrocławski

  8. Titanium Dioxide in a New Light: Reducing Toxicity and Improving the Photoprotective Properties of TiO2 Through Nanopart...

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Michał Jan Gackowski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  9. Development of novel 1,3-selenazol-2-one derivatives incorporated into self-emulsifying drug delivery systems as a strat...

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: dr hab. Robert Czarnomysy

    Uniwersytet Medyczny w Białymstoku

  10. "Green" Bioactive Dual-Layer Dressing for Controlled Neurotrophin and Analgesic Release to Support Nerve Regeneration in...

    Call: PRELUDIUM 24 , Panel: ST5

    Principal investigator: Anna Beata Zakrzewska

    Instytut Podstawowych Problemów Techniki Polska Akademia Nauk

  11. High Internal Phase Pickering Emulsions Stabilized with Solid Particles for Encapsulation of Lipophilic Drugs and Oxygen...

    Call: PRELUDIUM 24 , Panel: ST8

    Principal investigator: Weronika Adriana Kieres

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

  12. Hydrothermal surface phosphorylation as the key to the ideal implant – a new generation of implants capable of releasing...

    Call: PRELUDIUM 24 , Panel: ST11

    Principal investigator: Marcel Jakubowski

    Politechnika Poznańska

  13. Structural engineering of cell-penetrating peptides into biostable antibacterials to combat drug-resistant pathogens

    Call: OPUS 29 , Panel: NZ1

    Principal investigator: prof. Joanna Dominika Trylska

    Uniwersytet Warszawski

  14. Design and Pharmacological Evaluation of Marine Alkaloid-Inspired 5-HT2A Receptor Ligands

    Call: PRELUDIUM 24 , Panel: NZ1

    Principal investigator: Szymon Kazimierz Kordylewski

    Instytut Farmakologii PAN

  15. The role of IFN-γ in inducing phenotype alterations and disulfidptosis in drug-naïve and BRAFV600/MEK inhibitor-resistan...

    Call: PRELUDIUM 24 , Panel: NZ4

    Principal investigator: Piotr Wawrzyniak

    Uniwersytet Medyczny w Łodzi

  16. Smart Multiscale Encapsulation System: Hydrogel Macrocapsules with LbL Nanoparticles for Colorectal Cancer Treatment

    Call: PRELUDIUM 24 , Panel: ST11

    Principal investigator: Joanna Irena Szechyńska

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

  17. NMR Spectroscopy as Molecular Language: A Deep Learning Approach to Bioactivity Prediction

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Arkadiusz Bogumił Leniak

    Instytut Farmakologii PAN

  18. New aryl difluoromethylenephosphonic acid and thiazole conjugates as effective PTP1B inhibitors used in the treatment of...

    Call: PRELUDIUM 24 , Panel: ST5

    Principal investigator: Dominika Agnieszka Kołodziej-Sobczak

    Uniwersytet Mikołaja Kopernika

  19. Preparation of pollen-like advanced drug delivery carriers for the treatment of chronic obstructive pulmonary disease

    Call: SHENG 4 , Panel: ST5

    Principal investigator: prof. Elżbieta Pamuła

    Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie

  20. A new strategy to fight antibiotic resistance based on hybrids of fluoroquinolones and quaternary ammonium salts

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Joanna Dagmara Fedorowicz

    Gdański Uniwersytet Medyczny

  21. Investigating the properties of 3d–printed polymeric membranes as personalized dressings for hard-to-heal wounds.

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Ewelina Zofia Baran

    Uniwersytet Pedagogiczny im. Komisji Edukacji Narodowej w Krakowie

  22. Light-responsive biowaste-based sustainable 3D platform withon-demand drug release against bacterial infections in acute...

    Call: SONATA 20 , Panel: ST5

    Principal investigator: dr Alicja Kosik-Kozioł

    Instytut Podstawowych Problemów Techniki Polska Akademia Nauk

  23. The role of EZH2 activity in the development of resistance to targeted therapy in melanoma

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr Michał Jerzy Woźniak

    Uniwersytet Medyczny w Łodzi

  24. Janus nanoparticles - research on the effect of the duality of carriers of the activesubstance in targeted therapy of sk...

    Call: OPUS 28 , Panel: ST8

    Principal investigator: dr hab. Bożena Anna Tyliszczak

    Politechnika Krakowska im. Tadeusza Kościuszki

  25. Advancing Skeletal Muscle Tissue Engineering: Biologically Active Bioinks for Drug-Induced Disease Modelling and On-Dema...

    Call: OPUS 28 , Panel: ST8

    Principal investigator: prof. Wojciech Święszkowski

    Politechnika Warszawska

  26. Investigation of the mechanism of enhanced liposome delivery to tumors and its application for dual target immunotherapy

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr hab. Tomasz Piotr Rygiel

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  27. Fungal membrane modeling for selected antifungal compounds interactions

    Call: SONATA 20 , Panel: NZ9

    Principal investigator: dr Dominik Drabik

    Politechnika Wrocławska

  28. Smart Piezoelectric Bio-based Osteochondral Construct as a Model for Drug Testing and Implantation into Joint Defects

    Call: M-ERA.NET 3 Call 2024 , Panel: ST11

    Principal investigator: dr hab. Dorota Kołbuk-Konieczny

    Instytut Podstawowych Problemów Techniki Polska Akademia Nauk

  29. Parallel microevolution of metabolic plasticity and chemoresistance of cancer cells: a key to understanding cancer relap...

    Call: OPUS 28 , Panel: NZ3

    Principal investigator: prof. Jarosław Piotr Czyż

    Uniwersytet Jagielloński

  30. The first antibody-drug conjugates for Alzheimer's disease therapy

    Call: SONATA BIS 14 , Panel: NZ5

    Principal investigator: dr hab. Marcin Łukasz Poręba

    Politechnika Wrocławska

  31. Demonstration of the key role of vitamin B12 uptake in regulating Mycobacterium tuberculosis virulence lipids synthesis ...

    Call: SONATA BIS 14 , Panel: NZ6

    Principal investigator: dr Jakub Pawełczyk

    Instytut Biologii Medycznej PAN

  32. Molecular analyses of human dihydrouridine synthases acting on tRNA

    Call: SONATA BIS 14 , Panel: NZ1

    Principal investigator: dr Monika Ewelina Gaik

    Uniwersytet Jagielloński

  33. Supramolecular nanoparticles able to block calcium channels in cancer cells

    Call: SONATA BIS 14 , Panel: ST11

    Principal investigator: dr hab. Marek Brzeziński

    Centrum Badań Molekularnych i Makromolekularnych PAN

  34. Quad-TNT: Quadruplex-Targeted Photo-Therapy for Triple-Negative Tumors

    Call: SONATA BIS 14 , Panel: NZ5

    Principal investigator: dr Marco Deiana

    Politechnika Wrocławska

  35. A Fungal Hit Discovery Platform

    Call: JPIAMR ACTION Call 2024 , Panel: NZ1

    Principal investigator: dr Maria Magdalena Klimecka

    Uniwersytet Warszawski

  36. A new universal method for the isolation and deep proteomic characterization of extracellular vesicles to study drug res...

    Call: PRELUDIUM 23 , Panel: NZ2

    Principal investigator: Bianka Świderska

    Instytut Biochemii i Biofizyki PAN

  37. Dual Se-containing 5-HT1A and 5-HT7 biased agonists activating sigma-1 receptor as a hope of finding fast-acting antidep...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: prof. Karolina Anna Pytka

    Uniwersytet Jagielloński

  38. Disruption of the posttranslational activation of the translation factor EF-P as a new target for antimicrobial agents.

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: dr Piotr Wilk

    Uniwersytet Jagielloński

  39. Ecologies of representasion - visual discourses of Jews in interwar cartoons

    Call: PRELUDIUM 23 , Panel: HS2

    Principal investigator: Aleksandra Helena Guja

    Uniwersytet Jagielloński

  40. Strong bonds make perfect relationships. Covalent interactions between antibiotics and polymeric matrix as a key factor ...

    Call: PRELUDIUM 23 , Panel: ST5

    Principal investigator: dr Konrad Wojciech Kwiecień

    Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie

  41. Development of novel screening method for identifying xanthine oxidase inhibitors – towards new drug candidates for gout...

    Call: PRELUDIUM 23 , Panel: ST4

    Principal investigator: dr Monika Katarzyna Rola

    Politechnika Łódzka

  42. Assessment of long-term effects of semaglutide administered in repeated short cycles in obese mice

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: dr hab. Jakub Łukasz Wojcieszak

    Uniwersytet Medyczny w Łodzi

  43. Relocations of Music Collections in Poland After World War II

    Call: OPUS 27 , Panel: HS2

    Principal investigator: dr Tomasz Piotr Górny

    Uniwersytet Jagielloński

  44. A Compound Screening Platform for the Discovery of Histone- and Nucleosome-Targeting Agents

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: prof. Curtis Davey

    Uniwersytet Jagielloński

  45. Electrochemically Induced Release Systems Based on Conductive Surfaces Modified with Electroactive Microgels

    Call: PRELUDIUM 23 , Panel: ST5

    Principal investigator: Paulina Adriana Gwardys

    Uniwersytet Warszawski

  46. Precision double strike against non-small cell lung cancer. Insights into multidirectional therapies and the landscape o...

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: dr Katarzyna Anna Malarz

    Politechnika Śląska

  47. Exploiting the weakness of lymphoma: spectroscopic identification of biomarkers for lymphoma metabolism and inducing its...

    Call: PRELUDIUM 23 , Panel: ST4

    Principal investigator: Patrycja Dawiec

    Uniwersytet Jagielloński

  48. Evaluation of the relationship between doxorubicin resistance, epithelial-mesenchymal plasticity, and effects of selecte...

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Dominika Kunachowicz

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

  49. Evaluation of the role of miRNA as a peripheral biomarker of drug resistance in epilepsy using biosensors for electroche...

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: dr hab. Janusz Szyndler

    Warszawski Uniwersytet Medyczny

  50. Stealth" asparaginases as improved protein drugs for the treatment of childhood acute lymphoblastic leukemia (ALL)

    Call: OPUS 27 , Panel: NZ1

    Principal investigator: prof. Matthias Bochtler

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy